Balanced news tone
News Sentiment
ONCOZ sentiment intelligence
OncoZenge AB (publ) news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-8.7% over one week, -17.0% over four weeks, trend active, and materially above fair value.
OncoZenge Extends Payment Deadline In Directed Share Issue
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
OncoZenge Extends Payment Deadline In Directed Share Issue
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 05:50
- Source
- TradingView
OncoZenge has received partial payment of SEK 5.0 million for subscription proceeds in directed share issue and extends payment deadline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 15:15
- Source
- TradingView
OncoZenge Extends the Payment Deadline for Subscription Proceeds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- TradingView
Price to sales forward of OncoZenge AB – OMXSTO:ONCOZ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 19:09
- Source
- TradingView
OncoZenge AB Actuals & Estimates (OMXSTO:ONCOZ)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 16:06
- Source
- TradingView
OncoZenge Receives CTA Approval Milestone Payment From Molteni Farmaceutici
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 02 Jun 2026 07:00
- Source
- TradingView